Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Chotibut T, Meadows S, Kasanga EA, McInnis T, Cantu MA, Bishop C, Salvatore MF.

Mov Disord. 2017 Nov;32(11):1547-1556. doi: 10.1002/mds.27077. Epub 2017 Jun 20.

2.

Evolutionary dynamics with fluctuating population sizes and strong mutualism.

Chotibut T, Nelson DR.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Aug;92(2):022718. Epub 2015 Aug 20.

PMID:
26382443
3.

4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.

Carroll-Turpin M, Hebert V, Chotibut T, Wensler H, Krentzel D, Varner KJ, Burn BR, Chen YF, Abreo F, Dugas TR.

Toxicol Sci. 2015 Sep;147(1):235-45. doi: 10.1093/toxsci/kfv126. Epub 2015 Jun 26.

4.

Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals.

Chotibut T, Fields V, Salvatore MF.

Mol Pharmacol. 2014 Dec;86(6):675-85. doi: 10.1124/mol.114.093302. Epub 2014 Sep 10.

PMID:
25208966
5.

Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Chotibut T, Davis RW, Arnold JC, Frenchek Z, Gurwara S, Bondada V, Geddes JW, Salvatore MF.

Mol Neurobiol. 2014 Jun;49(3):1282-92. doi: 10.1007/s12035-013-8598-0. Epub 2013 Dec 3.

6.

Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.

Chotibut T, Apple DM, Jefferis R, Salvatore MF.

PLoS One. 2012;7(12):e52322. doi: 10.1371/journal.pone.0052322. Epub 2012 Dec 26.

7.

Influence of depression symptoms on history-independent reward and punishment processing.

Beevers CG, Worthy DA, Gorlick MA, Nix B, Chotibut T, Todd Maddox W.

Psychiatry Res. 2013 May 15;207(1-2):53-60. doi: 10.1016/j.psychres.2012.09.054. Epub 2012 Oct 30.

8.

Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19).

Salvatore MF, Davis RW, Arnold JC, Chotibut T.

Exp Neurol. 2012 Apr;234(2):428-36. doi: 10.1016/j.expneurol.2012.01.012. Epub 2012 Jan 17.

PMID:
22285253
9.

Normal aging and the dissociable prototype learning systems.

Glass BD, Chotibut T, Pacheco J, Schnyer DM, Maddox WT.

Psychol Aging. 2012 Mar;27(1):120-8. doi: 10.1037/a0024971. Epub 2011 Aug 29.

Supplemental Content

Loading ...
Support Center